BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6456421)

  • 21. Exposure to DMPA in pregnancy may cause low birth weight.
    Prog Hum Reprod Res; 1992; (23):2-3. PubMed ID: 12286194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depot medroxyprogesterone acetate contraception in women with medical problems.
    Frederiksen MC
    J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV; Castro S; Marchi NM; Marcovici M; Andrade LA; Fernandes A; Bahamondes L
    Contraception; 2014 Aug; 90(2):117-22. PubMed ID: 24613369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injectable contraception.
    Wilson E
    Practitioner; 1988 Jan; 232(1441):32-6. PubMed ID: 2975377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of long-term treatment with depot medroxy progesterone acetate for contraception on estrogenic activity.
    Taneepanichskul S; Patrachai S
    J Med Assoc Thai; 1998 Dec; 81(12):944-6. PubMed ID: 9916381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction.
    Kongsayreepong R; Chutivongse S; George P; Joyce S; McCone JM; Garza-Flores J; Valles de Bourges V; de La Cruz DL; Perez-Palacios G; Rosseneu M
    Contraception; 1993 Feb; 47(2):177-91. PubMed ID: 8449018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal study of lipids and blood pressure in relation to method of contraception in Latino women with prior gestational diabetes mellitus.
    Xiang AH; Kawakubo M; Buchanan TA; Kjos SL
    Diabetes Care; 2007 Aug; 30(8):1952-8. PubMed ID: 17519432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of medroxyprogesterone acetate contraception on human serum enzymes.
    Mukherjea M; Mukherjee P; Biswas R; Chakraborty AS; Kushari J
    Int J Fertil; 1981; 26(1):35-9. PubMed ID: 6113206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-acting contraceptive options.
    Kaunitz AM
    Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L; Marchi NM; Castro S; Juliato CT; Villarroel M; Bahamondes L
    Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statement on injectable contraception.
    International Planned Parenthood Federation IPPF
    IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women.
    Fahmy K; Khairy M; Allam G; Gobran F; Alloush M
    Contraception; 1991 Oct; 44(4):431-44. PubMed ID: 1836755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.
    Dennerstein GJ
    J Reprod Med; 1986 Sep; 31(9):801-3. PubMed ID: 2945926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pituitary reserve for gonadotrophins and prolactin in women under long-term use of depo-medroxyprogesterone acetate (DMPA) as a contraceptive.
    Mukasa FR; Sekadde-kigondu CB; Mati JK; Njoroge JK
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):160-3. PubMed ID: 12313677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma lipid changes and medroxyprogesterone acetate.
    Fraser IS
    Contracept Deliv Syst; 1983 Jan; 4(1):1-7. PubMed ID: 12264711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
    Ertopçu K; Inal MM; Ozelmas I
    Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facts about injectable contraception.
    Contracept Rep; 1994 Mar; 5(1):1-2. PubMed ID: 12287737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK; Sowers MR; Nichols S; Levy B
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose depot-medroxyprogesterone acetate (DMPA) - effects on lipid and lipoprotein metabolism.
    Crona N; Enk L; Samsioe G; Silfverstolpe G; Skryten A
    Eur J Obstet Gynecol Reprod Biol; 1983 Oct; 16(2):97-105. PubMed ID: 6227506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.